Ask AI
DESTINY Breast09
DESTINY-Breast09: Phase III Trial of Trastuzumab Deruxtecan ± Pertuzumab vs THP as 1L Treatment of HER2+ Advanced/Metastatic Breast Cancer

Released: June 04, 2025

Expiration: December 03, 2025

Activity

Progress
1
Course Completed
Activity Information

Released: June 04, 2025

Expiration: December 03, 2025